C

Castle Biosciences
D

CSTL

23.020
USD
-1.15
(-4.76%)
مغلق
حجم التداول
44,717
الربح لكل سهم
0
العائد الربحي
0
P/E
-263
حجم السوق
861,503,766
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ACN
    -2.48
    (-0.75%)
    328.07 USD
    CSCO
    -1.050
    (-2.17%)
    47.380 USD
    C
    CTSH
    0.690
    (0.91%)
    76.330 USD
    INFY
    0.175
    (0.79%)
    22.295 USD
    T
    TCS
    -0.04880
    (-5.51%)
    0.83650 USD
    W
    WIT
    -0.05500
    (-0.89%)
    6.10000 USD
الأخبار
المقالات

العنوان: Castle Biosciences

القطاع: Healthcare
الصناعة: Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.